InVivoMab anti-mouse BTLA (CD272)

Catalog number: BE0132_1mg
Brand: Bio X Cell
Packing: 1 mg
Other sizes: Other sizes available
Price: € 126.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoMab anti-mouse BTLA (CD272)

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Neutralisation/Blocking; Other Application
Species: Mouse
Host: Hamster
Clonality: Monoclonal
Isotype: IgG Kappa
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: 6A6
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab polyclonal Armenian hamster IgG (BE0091)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: 6A6; BE0132; BTLA; CD272; BTLA1; B- and T-lymphocyte-associated protein; B- and T-lymphocyte attenuator; B and T lymphocyte attenuator; B and T lymphocyte associated; BioXCell
Bekiaris V, Šedý JR, Macauley MG, Rhode-kurnow A, Ware CF. The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responses. Immunity. 2013;39(6):1082-1094. Read more
Steinberg MW, Huang Y, Wang-zhu Y, Ware CF, Cheroutre H, Kronenberg M. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection. PLoS ONE. 2013;8(10):e77992. Read more
Nakagomi D, Suzuki K, Hosokawa J, et al. Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivity. J Invest Dermatol. 2013;133(3):702-711. Read more
Tewalt EF, Cohen JN, Rouhani SJ, et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 2012;120(24):4772-82. Read more
Lepenies B, Pfeffer K, Hurchla MA, et al. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J Immunol. 2007;179(6):4093-100. Read more